MRI-guided radiation therapy for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether a special type of radiation therapy, guided by MRI, can treat prostate cancer with fewer side effects. The treatment is given in a highly precise way to target the cancer while sparing healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have low-risk or intermediate-risk prostate cancer as defined by your doctor.
- You must have had an MRI of your prostate within the last 6 months that shows a visible lesion, and that lesion must have been biopsied.
- Your cancer must be on one side of the prostate only.
- You cannot have had chemotherapy, biologic therapy, or immunotherapy within the last 21 days.
- You cannot be currently on or planning hormone therapy for prostate cancer.
- You cannot have had prior radiation therapy to the pelvic area.
- You cannot have had prior surgery or procedures that significantly altered your prostate anatomy.
- You cannot have active inflammatory bowel disease (like Crohn's disease or ulcerative colitis) affecting your rectum or sigmoid colon.
- You must be able to have an MRI (no incompatible metal implants, no severe claustrophobia, and able to lie flat for about 30-45 minutes).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a precise radiation technique that adapts to your body's daily changes. It may offer better outcomes for men with prostate cancer that hasn't spread outside the pelvic area.
This trial tests a newer way to treat certain low- to intermediate-risk prostate cancers using MRI guidance and an ultrasound probe placed through the urethra. It aims to destroy the tumor while using imaging to help target it more precisely.
This trial tests whether using MRI scans to guide radiation can allow lower doses to the healthy parts of the prostate, potentially reducing side effects. It is for men with intermediate- or high-risk prostate cancer that can be seen on MRI and has not spread.
This trial tests a precise, MRI-guided radiation treatment given over 7 days for people with prostate cancer in specific risk categories. It may help shrink or control the cancer while carefully targeting the tumor.
This study tests radiation treatment planned and guided using MRI scans (“image-guided radiotherapy”) for men with prostate cancer who are aiming for a cure. If you qualify, you may receive radiation with more precise targeting using MRI to help deliver treatment accurately.
This trial tests a newer way to plan and deliver radiation for prostate cancer using real-time MRI guidance. It may help by aiming high-dose treatment precisely while treating nearby disease and (in some cases) limited metastatic spots.
Hear when a new Stage I Prostate Cancer AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.